Therapeutic depletion of CCR8+ tumor-infiltrating regulatory T cells elicits antitumor immunity and synergizes with anti-PD-1 therapy.
Helena Van Damme,
Bruno Dombrecht,
Máté Kiss,
Heleen Roose,
Elizabeth Allen,
Eva Van Overmeire,
Daliya Kancheva,
Liesbet Martens,
Aleksandar Murgaski,
Pauline Madeleine Rachel Bardet,
Gillian Blancke,
Maude Jans,
Evangelia Bolli,
Maria Solange Martins,
Yvon Elkrim,
James Dooley,
Louis Boon,
Julia Katharina Schwarze,
Frank Tacke,
Kiavash Movahedi,
Niels Vandamme,
Bart Neyns,
Sebahat Ocak,
Isabelle Scheyltjens,
Lars Vereecke,
Frank Aboubakar Nana,
Pascal Merchiers,
Damya Laoui,
Jo Agnes Van Ginderachter
Mar 30, 2021
BACKGROUND: Modulation and depletion strategies of regulatory T cells (Tregs) constitute valid approaches in antitumor immunotherapy but suffer from severe adverse effects due to their lack of selectivity for the...